Questioning the excessive use of advanced treatment to remove organic micropollutants from wastewater

Environmental Science and Technology

Volumn 41, Issue 14, 2007, Pages 5085-5089

  Jones, Oliver A H ^a,d   Green, Pat G ^b   Voulvoulis, Nikolaos ^a   Lester, John N ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ANGLIAN WATER   (United Kingdom)

^c CRANFIELD UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISCHARGE (FLUID MECHANICS); ECOSYSTEMS; FILTRATION; HEALTH; MEMBRANES; NUTRIENTS; OZONE; SEWAGE;

ADVANCED TREATMENT TECHNIQUES; HYDRAULIC RETENTION; ORGANIC MICROPOLLUTANTS;

WASTEWATER TREATMENT;

ACTIVATED CARBON; CARBON DIOXIDE; ENDOCRINE DISRUPTOR; OZONE;

DISCHARGE (FLUID MECHANICS); ECOSYSTEMS; FILTRATION; HEALTH; MEMBRANES; NUTRIENTS; OZONE; SEWAGE; WASTEWATER TREATMENT;

ADSORPTION; COST-BENEFIT ANALYSIS; ENDOCRINE DISRUPTOR; FILTRATION; HEALTH RISK; ORGANIC POLLUTANT; OSMOSIS; POLLUTANT REMOVAL; SEWAGE TREATMENT; URBAN DRAINAGE; WASTEWATER;

ARTICLE; ECONOMIC ASPECT; ENERGY CONSUMPTION; ENVIRONMENTAL FACTOR; EVALUATION; EXHAUST GAS; FINANCIAL MANAGEMENT; HYDRAULIC CONDUCTIVITY; MEMBRANE FILTER; NONHUMAN; OXIDATION REDUCTION REACTION; REVERSE OSMOSIS; RISK ASSESSMENT; UNITED KINGDOM; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

ORGANIC CHEMICALS; WATER POLLUTANTS, CHEMICAL;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 34547181337     PISSN: 0013936X     EISSN: None     Source Type: Journal    
DOI: 10.1021/es0628248     Document Type: Article

References (38)

1. Birkett, J. W. In Endocrine Disrupters in Wastewater and Sludge Treatment; Birkett, J. W., Lester, J. N., Eds.; CRC Press: Boca Raton, FL, 2002; pp 35-58.
2. Tabak, H.; Bunch, H. L. Steroid hormones as water pollutants. Dev. Ind. Microbiol. 1970, 11, 367-376.
3. Hignite, C.; Azarnoff, D. L. Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicyclic acid in sewage water effluent. Life Sci. 1977, 20, 337-341.
4. Aherne, G. W.; Briggs, R. The relevance of the presence of certain synthetic steroids in the aquatic environment. J. Pharm. Pharmacol. 1989, 41, 735-736.
5. Dodds, E. C.; Goldgerg, L.; Lawson, W.; Robinson, R. Oestrogenic activity of certain synthetic compounds. Nature 1938, 141, 247-248.
6. Ashby, J.; Lefevre, P. A.; Odum, J.; Harris, C. A.; Routledge, E. J.; Sumpter, J. P. Synergy between synthetic oestrogens? Nature 1997, 385, 494.
7. Ramamoorthy, K.; Wang, F.; Chen, I.-C.; Safe, S.; Norris, J. D.; McDonnell, D. P.; Gaido, K. W.; Biochinfuso, W. P.; Korach, K. S. Potency of combined estrogenic pesticides. Science 1997, 275, 405-406.
8. Lai, K. M.; Scrimshaw, M. D.; Lester, J. N. The effects of natural and synthetic steroid estrogens in relation to their environmental occurrence. Crit. Rev. Toxicol. 2002, 32, 113-132.
9. Fent, K.; Weston, A. A.; Caminada, D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76, 122-159.
10. Cunningham, V. L.; Buzby, M.; Hutchinson, T.; Mastrocco, F.; Parke, N.; Roden, N. Effects of human pharmaceuticals on aquatic life: Next steps. Environ. Sci. Technol. 2006, 40, 3456-3462.
11. Oaks, J. L.; Gilbert, M.; Virani, M. Z.; Watson, R. T.; Meteyer, C. U.; Rideout, B. A.; Shivaprasad, H. L.; Ahmed, S.; Jamshed, M.; Chaudhry, I.; Arshad, M.; Mahmood, S.; Ali, A.; Khan, A. A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427, 630-633.
12. Lai, K. M.; Johnson, K. L.; Scrimshaw, M. D.; Lester, J. N. Binding of waterborne steroid estrogens to solid phases in river and estuarine systems. Environ. Sci. Technol. 2000, 34, 3890-3894.
13. Kolpin, D. W.; Furlong, E. T.; Meyer, M.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211.
14. Lai, K. M.; Scrimshaw, M. D.; Lester, J. N. Biotransformation and bioconcentration of steroid estrogens by Chlorella vulgaris. Appl. Environ. Microbiol. 2002, 68, 859-864.
15. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N. Partitioning of selected pharmaceutical compounds during activated sludge treatment. Arch. Environ. Contamin. Toxicol. 2006, 50, 297-305.
16. Gomes, R. L.; Deacon, H. E.; Lai, K. M.; Birkett, J. W.; Scrimshaw, M. D.; Lester, J. N. An assessment of the bioaccumulation of estrone in Daphnia magna. Environ. Toxicol. Chem. 2004, 23, 105-108.
17. Bound, J. P.; Voulvoulis, N. Pharmaceuticals in the aquatic environment - A comparison of risk assessment strategies. Chemosphere 2004, 56, 1143-1155.
18. Joss, A.; Andersen, H.; Ternes, T.; Richie, P. R.; Siegrist, H. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: Consequences for plant optimization. Environ. Sci. Technol. 2004, 38, 3047-3055.
19. Langford, K.; Lester, J. N. In Endocrine Disrupters in Wastewater and Sludge Treatment, 1st ed.; Birkett, J. W., Lester, J. N., Eds.; CRC Press: Boca Raton, FL, 2002; pp 103-144.
20. Johnson, A. C.; Sumpter, J. P. Removal of endocrine disrupting chemicals in activated sludge treatment works. Environ. Sci. Technol. 2001, 35, 4697-4703.
21. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N. The fate of human pharmaceuticals in wastewater treatment processes. Crit. Rev. Environ. Sci. Technol. 2005, 35, 401-427.
22. Burke, M. U.K. to tackle endocrine disrupters in wastewater. Environ. Sci. Technol. 2004, 38, 362-363.
23. Ternes, T. A.; Stuber, J.; Herrmann, N.; McDowell, D.; Ried, A.; Kampmann, M.; Teiser, B. Ozonation: A tool for the removal of pharmaceuticals, contrast media, and musk fragrances from wastewater? Water Res. 2003, 37, 1976-1982.
24. WRC. U.K. Water Industry Construction Cost Estimating Manual (TR61), version 7; Water Research Center (WRc): Swindon, U.K., 2003.
25. Ternes, T.; Joss, A.; Siegrist, H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol. 2004, 38, 392-399.
26. Andersen, H.; Siegrist, H.; Halling-Sorensen, B.; Ternes, T. A. Fate of estrogens in a municipal sewage treatment plant. Environ. Sci. Technol. 2003, 37, 4021-4026.
27. Graham, D. W.; Curtis, T. P. In Bioremediation: A Critical Review; Head, I. M., Sinleton, I., Milner, M. G., Eds.; Horizon Scientific Press: Norfolk, U.K., 2003; pp 60-92.
28. Vader, J. S.; van Ginkel, C. G.; Sperling, F. M. G. M.; de Jong, J.; de Boer, W.; de Graaf, J. S.; van der Most, M.; Stokman, P. G. W. Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 2000, 41, 1239-1243.
29. Miserez, K.; Philips, S.; Verstraete, W. New biology for advanced wastewater treatment. Water Sci. Technol. 1999, 40, 137-144.
30. Johnson, A. C.; Aerni, H.-R.; Gerritsen, A.; Gibert, M.; Giger, W.; Hylland, K.; Jürgens, M.; Nakari, T.; Pickering, A.; Suter, M. J.-F.; Svenson, A.; Wettstein, F. E. Comparing steroid estrogen and nonylphenol content across a range of European sewage plants with different treatment and management practices. Water Res. 2005, 39, 47-58.
31. Clara, M.; Strenn, B.; Ausserleitner, M.; Kreuzinger, N. Comparison of the behavior of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Water. Sci. Technol. 2004, 50, 29-36.
32. Jones, O. A. H.; Voulvoulis, N.; Lester, J. N. Pharmaceutical residues in the aquatic environment - A threat to drinking water? Trends Biotechnol. 2005, 23, 163-167.
33. Stackelberg, P. E.; Furlong, E. T.; Meyer, M. T.; Zaugg, S. D.; Henderson, A. K.; Reissman, D. B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking water treatment plant. Sci. Total Environ. 2004, 329, 99-113.
34. Kimura, K.; Toshima, S.; Amy, G.; Watanabe, Y. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci. 2004, 245, 71-78.
35. Sedlak, D. L.; Pinkston, K. E.; Gray, J. L.; Kolodziej, E. P. Approaches for quantifying the attenuation of wastewater-derived contaminants in the aquatic environment. Chimia 2003, 57, 567-569.
36. Zakkour, P. D.; Gaterell, M. R.; Griffin, P.; Cochin, R. J.; Lester, J. N. Developing a sustainable energy strategy for a water utility. Part II: A review of potential technologies and approaches. J. Environ. Manage. 2002, 66, 115-125.
37. Ashton, D.; Hilton, M.; Thomas, K. V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333, 167-184.
38. Roberts, P. H.; Thomas, K. V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356, 143-153.